LIMNW — Liminatus Pharma, Inc. Warrants
NASDAQ · Healthcare · Biotechnology
$0.04
+$0.00 (+0.00%)
Liminatus Pharma, Inc. Warrants (LIMNW) is a biotechnology company listed on NASDAQ. It is led by Chris Kim J.D., L.L.M., based in 6 Centerpointe Drive, La Palma, CA, United States, 90623. Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
Net income was -$2.0M.
Use this LIMNW page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LIMNW quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LIMNW SEC filings page. Lician reads the product cache first so this HTML stays unique to Liminatus Pharma, Inc. Warrants even when a live quote feed is slow.
About Liminatus Pharma, Inc. Warrants
Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
LIMNW Key Statistics
Market Cap
$0.00M
Volume
7,806
Previous Close
$0.04
Day Range
$0.04 – $0.04
EPS
-$0.07
Revenue
$0.00
Net Income
-$2.04M
Gross Profit
$0.00
Free Cash Flow
$0.00
LIMNW Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2025 | FY2025 | FY2025 | FY2024 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$2.04M | -$214.24K | -$255.00 | -$3.32M | -$2.72M |
| EPS (Diluted) | -$0.07 | $0.00 | -$2.55 | -$0.03 | -$0.05 |
Total Assets
$1.34M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$724.50K
Operating Cash Flow
-$9.58M
Free Cash Flow
$0.00
Liminatus Pharma, Inc. Warrants Company Information
- CEO, Treasurer & Secretary
- Chris Kim J.D., L.L.M.
- Headquarters
- 6 Centerpointe Drive, La Palma, CA, United States, 90623
- Website
- liminatuspharma.com
- Phone
- 213 273 5453
- IPO / Founded
- 2025-05-01
- Sector
- Healthcare
- Industry
- Biotechnology